Intensive Clotting Factor Prophylaxis Does Not Prevent Severe PPH in VWD – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Anne de Vaan et al, adding:
”Higher-Dosed Clotting Factor Prophylaxis Fails to Reduce Postpartum Hemorrhage in Women With von Willebrand Disease
A prospective Dutch study found that intensified prophylactic clotting factor therapy during pregnancy did not reduce severe postpartum hemorrhage rates in women with von Willebrand disease.”
Title: Higher-dosed clotting factor prophylaxis fails to reduce postpartum hemorrhage in women with von Willebrand disease: findings from the observational PRegnancy and Inherited bleeding DisordErS study
Authors: Anne de Vaan, Jeroen Eikenboom, Marieke Kruip, Marieke Punt, Saskia Schols, Floor Heubel-Moenen, Michiel Coppens, Laurens Nieuwenhuizen, Anja Mäkelburg, Marjolein Peters, Hans Duvekot, Annemieke Middeldorp, Kitty Bloemenkamp, Roger Schutgens, Titia Lely, Karin van Galen
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion